JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.21B |
| 2 |
Arthur J. Gallagher & Co
AJG
|
+$2.24B |
| 3 |
Walt Disney
DIS
|
+$2.18B |
| 4 |
Walmart Inc
WMT
|
+$1.96B |
| 5 |
McDonald's
MCD
|
+$1.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.77B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.64B |
| 3 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$2.5B |
| 4 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$2.23B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.61% |
| 2 | Technology | 23.17% |
| 3 | Financials | 10.12% |
| 4 | Consumer Discretionary | 9.84% |
| 5 | Healthcare | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
SFIX
4101
Stitch Fix
SFIX
$349M
| $1.73M | ﹤0.01% |
402,328
+241,103
| +150% | +$888K |
2018 Q2
26 quarters
|
|
4102
Atlas Energy Solutions
AESI
$1.51B
| $1.73M | ﹤0.01% |
78,072
-116,422
| -60% | -$2.51M |
2023 Q2
6 quarters
|
|
|
LEG
4103
DELISTED
Leggett & Platt
LEG
| $1.73M | ﹤0.01% |
180,354
-401,311
| -69% | -$4.8M |
2013 Q2
46 quarters
|
|
4104
Bitwise Crypto Industry Innovators ETF
BITQ
$424M
| $1.73M | ﹤0.01% |
102,476
-9,550
| -9% | -$168K |
2023 Q3
5 quarters
|
|
4105
Invesco S&P SmallCap 600 Revenue ETF
RWJ
$1.97B
| $1.72M | ﹤0.01% |
37,559
+18,544
| +98% | +$865K |
2015 Q2
38 quarters
|
|
4106
GraniteShares Gold Shares
BAR
$1.35B
| $1.72M | ﹤0.01% |
66,281
+9,771
| +17% | +$257K |
2021 Q1
15 quarters
|
|
4107
CALL
Chubb
CB
$128B
| $1.71M | ﹤0.01% |
6,200
-3,100
| -33% | -$880K |
2020 Q4
16 quarters
|
|
4108
CALL
BioNTech
BNTX
$24.3B
| $1.71M | ﹤0.01% |
15,000
| – | – |
2024 Q3
1 quarter
|
|
|
4109
PUT
BioNTech
BNTX
$24.3B
| $1.71M | ﹤0.01% |
15,000
| – | – |
2024 Q2
2 quarters
|
|
4110
Stoneridge
SRI
$192M
| $1.71M | ﹤0.01% |
272,460
+215,764
| +381% | +$1.66M |
2013 Q2
46 quarters
|
|
4111
First Trust Large Cap Value AlphaDEX Fund
FTA
$1.32B
| $1.71M | ﹤0.01% |
22,323
-1,268
| -5% | -$101K |
2013 Q4
44 quarters
|
|
4112
FLEX LNG
FLNG
$1.69B
| $1.71M | ﹤0.01% |
74,362
-39,358
| -35% | -$954K |
2021 Q2
14 quarters
|
|
4113
JPMorgan Diversified Return US Mid Cap Equity ETF
JPME
$458M
| $1.7M | ﹤0.01% |
16,591
+1,075
| +7% | +$114K |
2022 Q4
8 quarters
|
|
4114
Bally's
BALY
$711M
| $1.7M | ﹤0.01% |
94,979
+53,978
| +132% | +$952K |
2019 Q2
22 quarters
|
|
4115
Applied Digital
APLD
$7.59B
| $1.7M | ﹤0.01% |
222,383
+166,028
| +295% | +$1.38M |
2022 Q2
10 quarters
|
|
|
PSTX
4116
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $1.7M | ﹤0.01% |
176,956
+114,008
| +181% | +$595K |
2020 Q3
17 quarters
|
|
4117
VanEck BDC Income ETF
BIZD
$1.48B
| $1.7M | ﹤0.01% |
102,135
+91,850
| +893% | +$1.51M |
2022 Q4
8 quarters
|
|
4118
Allegiant Air
ALGT
$2.12B
| $1.7M | ﹤0.01% |
18,039
-2,816
| -14% | -$205K |
2015 Q1
39 quarters
|
|
4119
Forrester Research
FORR
$214M
| $1.7M | ﹤0.01% |
108,204
+102,976
| +1,970% | +$1.66M |
2016 Q2
34 quarters
|
|
4120
EverCommerce
EVCM
$1.58B
| $1.69M | ﹤0.01% |
152,010
+49,745
| +49% | +$556K |
2021 Q3
13 quarters
|
|
4121
Invesco China Technology ETF
CQQQ
$2.5B
| $1.69M | ﹤0.01% |
43,012
-4,193
| -9% | -$174K |
2020 Q3
17 quarters
|
|
|
VLRS
4122
Controladora Vuela Compania de Aviacion
VLRS
$746M
| $1.69M | ﹤0.01% |
227,601
+159,900
| +236% | +$1.2M |
2023 Q3
5 quarters
|
|
4123
State Street SPDR Bloomberg 3-12 Month T-Bill ETF
BILS
$3.87B
| $1.69M | ﹤0.01% |
17,049
+14,294
| +519% | +$1.42M |
2024 Q3
1 quarter
|
|
|
APGE
4124
DELISTED
Apogee Therapeutics
APGE
| $1.69M | ﹤0.01% |
37,255
+7,700
| +26% | +$393K |
2023 Q3
5 quarters
|
|
4125
Mizuho Financial
MFG
$132B
| $1.68M | ﹤0.01% |
343,786
+152,352
| +80% | +$703K |
2013 Q2
46 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2024 Portfolio in Review
As of Q4 2024, JP Morgan Chase held 7,917 positions worth $1.34T, up 2.1% from $1.32T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q4 2024 filing shows 509 new, 3,351 increased, 2,465 reduced and 522 closed positions. Its largest new stake was Primo Brands: 3,989,501 shares worth $123M. The largest sale was Eli Lilly, an estimated $2.77B.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 24% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q4 2024 buy was Primo Brands: 3,989,501 shares worth $123M.
- JP Morgan Chase added most to Broadcom in Q4 2024, an estimated $3.21B increase.
- JP Morgan Chase's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $2.77B.
- JP Morgan Chase fully exited Stericycle Inc in Q4 2024, selling an estimated $183M.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.34T portfolio in Q4 2024.
- JP Morgan Chase opened 509 new positions and closed 522 in Q4 2024.
- JP Morgan Chase's portfolio value rose 2.1% quarter-over-quarter to $1.34T.
Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.